2014
DOI: 10.1124/mol.114.095745
|View full text |Cite
|
Sign up to set email alerts
|

A Novel Pan-Negative-Gating Modulator of KCa2/3 Channels, Fluoro-Di-Benzoate, RA-2, Inhibits Endothelium-Derived Hyperpolarization–Type Relaxation in Coronary Artery and Produces Bradycardia In Vivo

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
11
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
6
3

Relationship

2
7

Authors

Journals

citations
Cited by 20 publications
(11 citation statements)
references
References 62 publications
0
11
0
Order By: Relevance
“…An indirect impact of TRAM‐34 or clotrimazole on autonomic input to SA and AV nodes in vivo can be excluded because both blockers exert similar effects on isolated SAN cells. In line with these data, RA‐2, a structurally different molecule from TRAM‐34 and clotrimazole, with a mixed blocker activity toward SK4 and SK2 channels, induced bradycardia in mice, an effect abolished in SK4 knockout mice (Olivan‐Viguera et al , ).…”
Section: Discussionmentioning
confidence: 69%
“…An indirect impact of TRAM‐34 or clotrimazole on autonomic input to SA and AV nodes in vivo can be excluded because both blockers exert similar effects on isolated SAN cells. In line with these data, RA‐2, a structurally different molecule from TRAM‐34 and clotrimazole, with a mixed blocker activity toward SK4 and SK2 channels, induced bradycardia in mice, an effect abolished in SK4 knockout mice (Olivan‐Viguera et al , ).…”
Section: Discussionmentioning
confidence: 69%
“…B,C). The negative‐gating modulator, RA‐2 (1 μM), that directly suppresses positive‐gating modulation potently blocked all K Ca current (not shown) and a small TRAM‐34/UCL‐1684‐resistant K Ca current (fig. B,C), which may suggest incomplete block of porcine K Ca 3.1 by the pore blocker, TRAM‐34 .…”
Section: Resultsmentioning
confidence: 93%
“…) or the novel negative‐gating modulator, the dibenzoate ester, RA‐2 (Olivan‐Viguera et al . ), may prevent lung oedema formation when applied from the bronchial side to minimize potential systemic effects on blood pressure. While this is hypothetical for the lung, there are studies on the brain that suggest such utilities for prevention of oedema: a cyclohexadiene compound efficiently reduces brain oedema in a rat acute subdural haematoma model (Mauler et al .…”
Section: Do Kca31 Blockers Have Therapeutic Utility Against Pulmonarmentioning
confidence: 99%